DEXCOM, INC. Unrealized Gain (Loss) on Investments
DEXCOM, INC. (DXCM) reported Unrealized Gain (Loss) on Investments of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2021-02-11
- DEXCOM, INC. unrealized gain (loss) on investments for the quarter ending 2019-12-31 was $0.00.
- DEXCOM, INC. unrealized gain (loss) on investments for the quarter ending 2018-12-31 was -$4.80M.
- DEXCOM, INC. unrealized gain (loss) on investments for the quarter ending 2018-09-30 was -$9.30M.
- DEXCOM, INC. unrealized gain (loss) on investments for the quarter ending 2018-06-30 was $42.70M.
- DEXCOM, INC. unrealized gain (loss) on investments for fiscal 2020 was $0.00.
- DEXCOM, INC. unrealized gain (loss) on investments for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- DEXCOM, INC. unrealized gain (loss) on investments for fiscal 2018 was $36.00M.
- DEXCOM, INC. unrealized gain (loss) on investments for fiscal 2017 was $0.00.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-11 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $0.00 10-K · filed 2021-02-11 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 | |||
| 2018-12-31 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$14.10M derived: sum of 2 quarters · filed 2021-02-11 | $28.60M derived: sum of 3 quarters · filed 2021-02-11 | $36.00M 10-K · filed 2021-02-11 |
| 2018-09-30 | -$9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $33.40M derived: sum of 2 quarters · filed 2019-11-06 | $40.80M 10-Q · filed 2019-11-06 | $40.80M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $42.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $50.10M 10-Q · filed 2018-08-01 | $50.10M derived: sum of 3 quarters · filed 2020-02-13 | $50.10M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $7.40M 10-Q · filed 2018-05-02 | $7.40M derived: sum of 2 quarters · filed 2020-02-13 | $7.40M derived: sum of 3 quarters · filed 2020-02-13 | $7.40M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | $0.00 derived: sum of 3 quarters · filed 2020-02-13 | $0.00 10-K · filed 2020-02-13 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $0.00 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-02 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |